RecruitingPhase 4NCT03765567

Placement of Antibiotic Powder in Wounds During the Emergency Room

Placement of Antibiotic Powder in Wounds During the Emergency Room (POWDER) Study


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

200 participants

Start Date

Oct 5, 2020

Study Type

INTERVENTIONAL

Summary

This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria4

  • Subject or Legal Authorized Representative (LAR) is willing and able to provide written informed consent.
  • Adult 18 years of age or older.
  • Open fracture of the humerus, radius, ulna, femur, tibia, and/or fibula.
  • hours or less has elapsed from the estimated time of injury to study intervention.

Exclusion Criteria8

  • Time from injury > 24 hours.
  • Subjects who have received acute operative care (e.g., washout in the operating room or fixation) of the open fracture at an outside facility.
  • Subject or LAR speaks neither English nor Spanish. Note that subjects that are unable to participate in the consent process (e.g. intoxication, poly-trauma, will be enrolled into the observational arm where passive data collection will occur).
  • High-potency antibiotic powder or solution applied to the wound prior to enrollment. Simple ointment (i.e., bacitracin ointment) or antibiotic-impregnated dressings will be permitted.
  • Documented allergies or serious reactions to vancomycin. History of uncomplicated "red man syndrome" will not be considered a reason for exclusion.
  • Pregnant subjects. If the subject is a female of childbearing potential, and she states that she is likely to be pregnant, a pregnancy test will be performed; if negative, the subject will be eligible for enrollment.
  • Prisoners.
  • Participation in other clinical research involving investigational antimicrobial products within 30 days of randomization.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVancomycin

2 vials of Vancomycin 1g powder will be applied topically to the open fracture wound site.


Locations(2)

University Hospital

San Antonio, Texas, United States

San Antonio Military Medical Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03765567